Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Analytical Cellular Pathology (Amsterdam)
|
October 28, 2010
VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin
Michelle J Nyhan, Shereen M El Mashad, Tracey R O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis
Jonathan I Izawa, Paul Sweeney, Paul Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2003
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB
Badar M Mian, Colin P N Dinney, Carlos E Bermejo, et al.
Neoplasia (New York, N.Y.)
|
October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
Khalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
CJC Open
|
May 24, 2021
Screening for Obstructive Sleep Apnea in an Atrial Fibrillation Population: What's the Best Test?
Samantha Y Starkey, Daniel R Jonasson, Stephanie Alexis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production
Paul Sweeney, Takashi Karashima, Sun-Jin Kim, et al.
Clinical Genitourinary Cancer
|
January 22, 2013
Translocation renal cell carcinomas: an evolving entity and a member of the microphthalmia transcription factor-associated family of tumors
Richard M Bambury, Jodie E Battley, Aoife McCarthy, et al.
The Journal of Urology
|
May 29, 2003
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
Paul Sweeney, Randall Millikan, Machelle Donat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice
Takashi Karashima, Paul Sweeney, Joel W Slaton, et al.
Urologic Oncology
|
December 13, 2003
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi
Paul Sweeney, Christopher G Wood, Louis L Pisters, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Analytical Cellular Pathology (Amsterdam)
|
October 28, 2010
VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin
Michelle J Nyhan, Shereen M El Mashad, Tracey R O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis
Jonathan I Izawa, Paul Sweeney, Paul Perrotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2003
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB
Badar M Mian, Colin P N Dinney, Carlos E Bermejo, et al.
Neoplasia (New York, N.Y.)
|
October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
Khalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
CJC Open
|
May 24, 2021
Screening for Obstructive Sleep Apnea in an Atrial Fibrillation Population: What's the Best Test?
Samantha Y Starkey, Daniel R Jonasson, Stephanie Alexis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production
Paul Sweeney, Takashi Karashima, Sun-Jin Kim, et al.
Clinical Genitourinary Cancer
|
January 22, 2013
Translocation renal cell carcinomas: an evolving entity and a member of the microphthalmia transcription factor-associated family of tumors
Richard M Bambury, Jodie E Battley, Aoife McCarthy, et al.
The Journal of Urology
|
May 29, 2003
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
Paul Sweeney, Randall Millikan, Machelle Donat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice
Takashi Karashima, Paul Sweeney, Joel W Slaton, et al.
Urologic Oncology
|
December 13, 2003
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi
Paul Sweeney, Christopher G Wood, Louis L Pisters, et al.
Page
of 6